Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

Clinical trial NCT06648772 · COMPLETED

Trial details

NCT number: NCT06648772
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2024-11-14
Primary completion: 2025-10-13
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.